Research ArticleArticle
Open Access
Long-term Safety and Effectiveness of Tacrolimus in Patients With Lupus Nephritis: 5-year Interim Postmarketing Surveillance Study in Japan (TRUST)
Tsutomu Takeuchi, Naoko Wakasugi, Satoshi Uno and Hirofumi Makino
The Journal of Rheumatology April 2020, jrheum.191008; DOI: https://doi.org/10.3899/jrheum.191008
Tsutomu Takeuchi
This work was supported by Astellas Pharma, Inc. Editorial support was funded by Astellas Pharma, Inc. T. Takeuchi MD, PhD, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo; N. Wakasugi, MSc, S. Uno, MSc, Astellas Pharma Inc., Tokyo; H. Makino MD, PhD, Okayama University, Okayama-Shi, Japan. All authors report nonfinancial support from Astellas during the development of the manuscript. N. Wakasugi and S. Uno are employees of Astellas. Full Release Article. For details see Reprints and Permissions at jrheum.org. Address correspondence to N. Wakasugi, Astellas Pharma Inc., 2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo 103-8411, Japan. Email: naoko.wakasugi@astellas.com. Accepted for publication March 10, 2020.
Naoko Wakasugi
This work was supported by Astellas Pharma, Inc. Editorial support was funded by Astellas Pharma, Inc. T. Takeuchi MD, PhD, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo; N. Wakasugi, MSc, S. Uno, MSc, Astellas Pharma Inc., Tokyo; H. Makino MD, PhD, Okayama University, Okayama-Shi, Japan. All authors report nonfinancial support from Astellas during the development of the manuscript. N. Wakasugi and S. Uno are employees of Astellas. Full Release Article. For details see Reprints and Permissions at jrheum.org. Address correspondence to N. Wakasugi, Astellas Pharma Inc., 2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo 103-8411, Japan. Email: naoko.wakasugi@astellas.com. Accepted for publication March 10, 2020.
Satoshi Uno
This work was supported by Astellas Pharma, Inc. Editorial support was funded by Astellas Pharma, Inc. T. Takeuchi MD, PhD, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo; N. Wakasugi, MSc, S. Uno, MSc, Astellas Pharma Inc., Tokyo; H. Makino MD, PhD, Okayama University, Okayama-Shi, Japan. All authors report nonfinancial support from Astellas during the development of the manuscript. N. Wakasugi and S. Uno are employees of Astellas. Full Release Article. For details see Reprints and Permissions at jrheum.org. Address correspondence to N. Wakasugi, Astellas Pharma Inc., 2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo 103-8411, Japan. Email: naoko.wakasugi@astellas.com. Accepted for publication March 10, 2020.
Hirofumi Makino
This work was supported by Astellas Pharma, Inc. Editorial support was funded by Astellas Pharma, Inc. T. Takeuchi MD, PhD, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo; N. Wakasugi, MSc, S. Uno, MSc, Astellas Pharma Inc., Tokyo; H. Makino MD, PhD, Okayama University, Okayama-Shi, Japan. All authors report nonfinancial support from Astellas during the development of the manuscript. N. Wakasugi and S. Uno are employees of Astellas. Full Release Article. For details see Reprints and Permissions at jrheum.org. Address correspondence to N. Wakasugi, Astellas Pharma Inc., 2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo 103-8411, Japan. Email: naoko.wakasugi@astellas.com. Accepted for publication March 10, 2020.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Long-term Safety and Effectiveness of Tacrolimus in Patients With Lupus Nephritis: 5-year Interim Postmarketing Surveillance Study in Japan (TRUST)
Tsutomu Takeuchi, Naoko Wakasugi, Satoshi Uno, Hirofumi Makino
The Journal of Rheumatology Apr 2020, jrheum.191008; DOI: 10.3899/jrheum.191008